Clinical Trials Browser

Disease × Doxorubicin × Breast × Clear all

NCT00128856 2023-03-06

Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients

Phase 2 Completed

Breast Neoplasms, Disease